Suchergebnisse - "Daratumumab"

PubPharm (1.028)

1

CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123

enthalten in: Leukemia research | 2024

von Hu, X. | Ediriwickrema, A. | Saleem, A. | +3

2

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy

enthalten in: British journal of haematology | 2024

von Venglar, O. | Kapustova, V. | Anilkumar Sithara, A. | +16

3

CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Sharma, A. | Gupta, K. | Mishra, A. | +9

UpdateOf: bioRxiv. 2023 Oct 31;:. - PMID 37214794

4

Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients : Single-arm, open-label, phase I study

enthalten in: Annals of hematology | 2024

von Shi, H. | Yang, F. | Cao, M. | +11

5

Novel monoclonal antibodies : A really specific therapy for light chain amyloidosis

enthalten in: Hematological oncology | 2024

von Del Giudice, M. | Galimberti, S. | Buda, G.

6

Daratumumab‑resistant multiple myeloma with extramedullary disease successfully treated with combination elotuzumab, pomalidomide and dexamethasone : A case report

enthalten in: Oncology letters | 2024

von Sakashita, M. | Sahara, N. | Aoki, J. | +5

7

Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

enthalten in: International journal of hematology | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

8

Evaluating the HYDRASHIFT 2/4 Daratumumab assay : a powerful approach to assess treatment response in multiple myeloma

enthalten in: Clinical chemistry and laboratory medicine | 2024

von Lee, H. | Kim, S. | Park, H.

9

Four-Drug Therapy for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sampath, V.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

10

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[103]